Intravenous sedation for placement of automatic implantable cardioverter-defibrillators.
OBJECTIVE
To evaluate a change in anesthetic technique for transvenous placement of the automatic implantable cardioverter-defibrillator (ICD).


METHODS
Retrospective study.


METHODS
A university hospital.


METHODS
Twenty-eight patients who underwent placement of ICDs.


METHODS
Thirteen patients had the ICD placed via the transvenous approach with general anesthesia (group GA). Fifteen patients had the ICD placed via the transvenous approach with intravenous sedation (group IV).


RESULTS
Intraoperative systolic and diastolic blood pressures were significantly higher in group IV compared with group GA. The ICD was successfully placed in all patients in both groups. There were no intraoperative complications noted in either group during induction of fibrillation and defibrillation, and there was no recall by any patient in either group. The average hospital stay was significantly less in group IV (1.8 days) compared with group GA (3.4 days).


CONCLUSIONS
Intravenous sedation for the placement of ICDs is a safe and effective technique. Patients who had their ICD placed while receiving intravenous sedation experienced higher intraoperative blood pressures and were discharged from the hospital earlier than those patients who received general anesthesia.
Department of Anesthesiology, Medical University of South Carolina, Charleston 29425-2207, USA.
M L
ML
Pinosky
S T
ST
Reeves
R L
RL
Fishman
C C
CC
Alpert
B H
BH
Dorman
J M
JM
Kratz
D000368:Aged; D000768:Anesthesia, General; D017147:Defibrillators, Implantable; D005260:Female; D005283:Fentanyl / Q000008:administration & dosage; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage*; D008297:Male; D008874:Midazolam / Q000008:administration & dosage*; D008875:Middle Aged; D012189:Retrospective Studies
D006993:Hypnotics and Sedatives; D008874:Midazolam; D005283:Fentanyl